STAT+: Early data suggest monthly hemophilia drug could contend with gene therapy
Centessa, a biotech company that raised more than $300 million in an IPO earlier this…
Category: STAT+
.jpg)
Opinion: STAT+: Digital clinical trials can personalize patient engagement, accelerate therapy development
Biopharmaceutical companies were conducting more than 9,000 clinical trials in the U.S. in March 2020…
.jpg)
STAT+: Pharmalittle: Sanofi will acquire Kadmon Pharma for $1.9 billion; Theranos founder Elizabeth Holmes goes on trial
Good morning. Happy Wednesday. This is Kate Sheridan, filling in for Ed Silverman this morning…
STAT+: In another sign of RNA’s growing popularity, the cancer startup Replicate is relaunching
A California startup is putting a new spin on a now-familiar idea: using RNA as…
STAT+: Inside Verily’s make-or-break push to turn its most promising ideas into profits
It’s a make or break moment for Verily, as the sprawling Google offshoot rapidly accelerates…
STAT+: FDA dings Kaleido Biosciences for testing a microbiome drug without proper paperwork
The Food and Drug Administration is warning Lexington, Mass.-based Kaleido Biosciences that it shouldn’t have…
STAT+: STAT+ Conversation: Which biotech venture capitalist funds performed best during the pandemic?
Editor’s note: A livestream of the conversation will be embedded below at 2 p.m. ET….
STAT+: Pharmalittle: CEPI warns of hurdle to new Covid-19 vaccines; reading tea leaves on booster side effects
G’morning to ya! Nicholas St. Fleur here to fill in for Ed following this Labor…
STAT+: The FDA has just 3 days to decide how to regulate 6.5 million e-cigarette products. But what if it blows past the deadline?
WASHINGTON — The Food and Drug Administration has just three days until it must finally…
STAT+: Democrats want to let Medicare negotiate drug prices. Has pharma found a way to lessen the blow, already?
WASHINGTON — As Democrats design a way to use the government’s leverage to lower drug…
STAT+: Pharmalittle: Lawmakers ramp up probe of FDA approval of Biogen drug; EU to return J&J Covid-19 shots to Africa
And so, another working week will soon draw to a close. Not a moment too…
Opinion: STAT+: A 10-point plan for sustaining the biopharma industrial base for a more secure nation
Covid-19 has underscored the critical role the biopharma industrial base plays in the U.S.’s national…
STAT+: Cityblock Health raises another mega-round of funding, tipping its valuation over $5 billion
Cityblock Health, a startup using technology to deliver well-rounded primary care to people covered by…
STAT+: Older job seekers claim that Lilly favors millennials when it comes to hiring sales reps
In order to win the attention of physicians, Eli Lilly (LLY) has deliberately sought to…
STAT+: Boston Scientific completes $1 billion acquisition of Israeli firm
Boston Scientific’s shopping spree for smaller medical-device companies continued on Wednesday when the Marlborough-based company…
STAT+: Pharmalittle: Purdue bankruptcy plan is approved but appeals expected; FDA warns about safety risks with arthritis drugs
Top of the morning to you. And a fine one it is. Lots of sunshine…
STAT+: The next front in the health care cloud wars
After a mad rush to roll out telehealth offerings during the pandemic, the value of…
STAT+: Pharmalittle: Two key FDA officials leaving amid Covid-19 booster debate; is Biden really ‘following the science’?
Hello, everyone, and welcome to the middle of the week. You made it this far,…
STAT+: The 10 power players to watch on Democrats’ drug pricing push
WASHINGTON — In the coming weeks, Democrats will embark on an ambitious effort to change…
STAT+: Two top FDA officials in charge of Covid-19 vaccines to leave agency this fall
WASHINGTON — The two officials in charge of leading the FDA’s review of coronavirus vaccine…
STAT+: Pharmalittle: BIO wrestles with inner turmoil; J&J HIV vaccine failed to prevent infection
Hello, everyone, and how are you today? We are doing just fine, thank you, despite…
STAT+: ‘Change is messy’: Inside the tumultuous efforts to stabilize BIO, the biotech lobby
WASHINGTON — The Biotechnology Innovation Organization, the lobbying group that represents roughly 1,000 biotech companies,…
STAT+: ‘A step in the right direction for national security’: An antibiotic plant reopens in Tennessee to make penicillin
Amid a push to bolster antibiotic manufacturing in the U.S., a facility that closed last…
STAT+: Flagship’s Laronde raises $440 million for a new class of medicines
Flagship Pioneering, the Cambridge, Mass., venture capital firm, brought biotech startup Laronde out of stealth…
STAT+: Pharmalittle: Contaminants found in Moderna Covid-19 vaccine in Japan; demand rises for ivermectin to treat the coronavirus
Good morning, everyone, and nice to see you again. We have returned from a week-long…
STAT+: 4 ways Elizabeth Holmes could win over a jury
Elizabeth Holmes may be guilty in the minds of millions who consumed the best-selling book,…
STAT+: Pharmalittle: Judge delays ruling on Purdue opioid settlement; Biomarin dwarfism drug cleared in Europe
Good day, everyone! Nick Florko here filling in for the great Ed Silverman. I’m here…
STAT+: Biden health department hires four outside firms to audit Covid-19 grants to hospitals
WASHINGTON — The Biden administration has hired several separate outside contractors to police the billions…
STAT+: Pharmalittle: Judge plans to rule on Purdue settlement Friday; Biden administration considering Covid boosters after six months
Good morning, fellow humans. Erin Brodwin here, filling in for Ed Silverman. My unofficial mascot,…
STAT+: The Theranos scandal cast a pall over self-testing. The pandemic is giving the industry another shot
This could have been Elizabeth Holmes’ moment. When the then-19-year-old founded Theranos in 2003, she…
STAT+: Sesen Bio pulls E.U. application for FDA-rejected cancer drug
Sesen Bio, a small biotech firm whose investigational cancer treatment once seemed poised for approval,…
STAT+: Pharmalittle: Second J&J vaccine dose boosts antibodies against Covid; age lowered for diabetes screening
Good morning! Katie Palmer here, tagging in for Ed Silverman as he embraces the final…
Pharmalittle: New wave of employer Covid-vaccine mandates expected; drug makers and FDA agree on new programs for rare-disease drugs
Good morning! This is Lev Facher, subbing today for Ed Silverman. I’d be remiss not…
Opinion: STAT+: Bringing clarity and consistency to CMS’s hospital price transparency rule will be a win for all
The Centers for Medicare and Medicaid Services’ (CMS) price transparency rule requiring U.S. hospitals to…
STAT+: Will breaking apart Google’s health bets give them a better shot at success?
Google is once again overhauling its ambitious health efforts. But this time around, some experts…
STAT+: Elizabeth Holmes will be on trial. But the evidence will expose a bigger collision between tech culture and health care
When the long-awaited trial of former Theranos CEO Elizabeth Homes opens at the end of…
STAT+: FDA, drug makers propose new pilots aimed at speeding rare disease drugs, as part of user fee update
WASHINGTON — The Food and Drug Administration and the drug industry have jointly agreed to…
STAT+: Four takeaways on Pfizer’s $2.3 billion purchase of Trillium
Pfizer said Monday that it is buying Trillium, a Toronto developer of cancer drugs with…
STAT+: Pharmalittle: Pfizer to buy Trillium in $2.3 billion deal; Israel data find additional vaccine dose lowers Covid risk
Good morning everyone, hope you’re savoring the fresh start that comes with the beginning of…
STAT+: Flagship, Orbimed, ARCH, Alta top list of high-performing biotech venture capital firms
Flagship Pioneering is on track to return its investors’ money an eye-popping 15 times over,…
STAT+: SENS Research Foundation removes Aubrey de Grey over concerns he was interfering in sexual harassment investigation
Antiaging science’s most prominent prophet, Aubrey de Grey, has been removed from his post as…
STAT+: Biotech founder David Sabatini placed on leave following investigation into sexual harassment
A prominent biology professor and biotech founder at the Massachusetts Institute of Technology has been…
STAT+: Pharmalittle: Biden reportedly rules out Woodcock as FDA commish; J&J’s Gorsky is stepping aside as CEO
And so, another working week will soon draw to a close. Not a moment too…
STAT+: After company protest, FDA agrees to review controversial drug to prevent premature birth
In an unexpected turn of events, the Food and Drug Administration will hold a hearing…
Feinberg to leave Google Health for Cerner
David Feinberg has left his post as the leader of Google Health for health care…
STAT+: A new technology, based on a quirk of evolutionary biology, may be the next big thing for CRISPR
On a chilly morning last November, Michael Segel stepped through the glass doors of the…
STAT+: Medical journal editorial writers have financial conflicts of interest, too
In the latest look at conflicts of interest in science, a new analysis found 15%…
STAT+: Pharmalittle: FDA advisory panel members want negative votes to matter more; Illumina closes Grail deal despite regulatory hurdles
Good morning, folks. How are you today? Once again, sunny skies and a cool breeze…
STAT+: WHO urges Roche to ensure equitable access of Covid-19 treatment amid global shortage
The World Health Organization and Unitaid called on Roche (RHHBY) to ensure that existing doses…
STAT+: Pharmalittle: Sesen Bio drug trial marked by misconduct; a Sackler threatens opioid settlement if immunity not granted
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle…